| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
| 2022 | 1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer | Verschraegen, Claire; Andric, Zoran G   ; ...; (broj, koautora 20) | Конференцијски рад | |
| 2024 | 3-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer | Verschraegen, C; Andric, Zoran G ; Moiseenko, FV; Makharadze, T; Oleksiienko, A; Ruiz, EP Yanez; Kim, SH; Ahn, K; Park, TH; Ju, HA;
Baek, EH; Kwon, S; Lee, SJ; Chang, I; Kim, SH; Kim, HA; Lee, E; Ohe, Y;
| Конференцијски рад | |
| 2022 | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial | Verschraegen, Claire; Andric, Zoran G ; Moiseenko, Fedor; Makharadze, Tamta; Shevnya, Sergii; Oleksiienko, Alona; Ruiz, Eduardo Yanez; Kim, SungHyun; Ahn, KeumYoung; Park, TaeHong;
Park, Sijin; Ju, Hana; Ohe, Yuichiro;
| Научни чланак | 21aM21a - Водећи међународни часопис категорије M21a |
| 2015 | Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents | Karmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20) | Научни чланак | 21aM21a - Водећи међународни часопис категорије M21a |
| 2017 | Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice | Ben-Horin, Shomron; ...; Protic, Marijana B; ...; (broj, koautora 17) | Научни чланак | 22M22 - Међународни часопис категорије M22 |
| 2023 | Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases | Schreiber, Karen; ...; Vojinovic, Jelena ; ...; (broj, koautora 90) | Информативни прилог | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2025 | Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer | Andric, Zoran ; ...; (broj, koautora 16) | Научни чланак | 22M22 - Међународни часопис категорије M22 |
| 2025 | Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY) | Colombel, Jean Frederic; ...; Sreckovic, Slobodan; ...; (broj, koautora 33) | Научни чланак | 21aM21a - Водећи међународни часопис категорије M21a |
| 2024 | Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY) | Hanauer, Stephen B; ...; Sreckovic, Slobodan; ...; (broj, koautora 33) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2020 | Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management | Matucci-Cerinic, Marco; ...; Damjanov, Nemanja S; ...; (broj, koautora 20) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |